Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00269620 · ClinicalTrials.gov registry record · Phase 4
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
A Phase 4 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 4
- Development phase
- 500
- Enrollment target
NCT00269620: Completed Phase 4 study, sponsored by University of Pittsburgh.
NCT00269620 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 500 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00269620, a Phase 4 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 500 participants
- Enrollment target
Study Summary
This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four months. Women must either be on the pill or have recently stopped the pill and be relatively satisfied with oral contraceptive use to qualify for enrollment. Two visits and two phone calls will be required.
Interventions
- DRUG ethinyl estradiol/etonogestrel vaginal ring
- DRUG ethinyl estradiol/norelgestromin transdermal contraceptive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00269620 record still lists
NCT00269620 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which ethinyl estradiol/etonogestrel vaginal ring is the first listed.
NCT00269620 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00269620 about?
NCT00269620 is a clinical study titled "PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra". This is an open-label prospective, multicenter, randomized trial to compare continuation rates into the fourth cycle of women using either the NuvaRing or OrthoEvra. Five hundred women will be recruited at 9 centers nationwide to be randomly assigned to use either the NuvaRing or OrthoEvra for four ...
What is the current status of trial NCT00269620?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 500 participants. The study started on 2005-06. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00269620?
The interventions under investigation include: ethinyl estradiol/etonogestrel vaginal ring (DRUG), ethinyl estradiol/norelgestromin transdermal contraceptive (DRUG).
Who is sponsoring clinical trial NCT00269620?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00269620's enrollment target sits among peer trials
500 165th of 2000 higher than 1,824 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia